Tvardi Therapeutics (TVRD) Current Deferred Revenue (2013 - 2020)
Tvardi Therapeutics (TVRD) posted Current Deferred Revenue of $511,000 for Q3 2020, down 98.1% from $26.77 million a year earlier and down 94.8% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Current Deferred Revenue (2013 - 2020) Analysis & Trends
At the end of FY2019, Tvardi Therapeutics' Current Deferred Revenue came in at $22.26 million, down 17.0% from FY2018.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of 72.6% (FY2014 to FY2019).
- In prior years, Tvardi Therapeutics' Current Deferred Revenue was $26.83 million in FY2018.
- The Q3 2020 figure stands as the lowest quarterly Current Deferred Revenue since Q2 2015.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last five quarters, with an average decline of 36.2% over the last six quarters.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $9.77 million (Q2 2020), $14.24 million (Q1 2020) and $22.26 million (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Tvardi Therapeutics | 11.73 Mn | 11.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 511,000.00 |
| Jun 30, 2020 | 9.77 Mn |
| Mar 31, 2020 | 14.24 Mn |
| Dec 31, 2019 | 22.26 Mn |
| Sep 30, 2019 | 26.77 Mn |
| Jun 30, 2019 | 26.47 Mn |
| Mar 31, 2019 | 28.19 Mn |
| Dec 31, 2018 | 26.83 Mn |
| Sep 30, 2018 | 29.24 Mn |
| Jun 30, 2018 | 22.27 Mn |
| Jun 30, 2015 | 89,000.00 |
| Mar 31, 2015 | 963,000.00 |
| Dec 31, 2014 | 1.45 Mn |
| Sep 30, 2014 | 1.94 Mn |
| Jun 30, 2014 | 3.07 Mn |
| Mar 31, 2014 | 3.42 Mn |
| Dec 31, 2013 | 3.48 Mn |
API Access
Tvardi Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();